Mazor Robotics Ltd – ADR (MZOR) reported quarterly earnings results on Tuesday, May-10-2016. The company reported $-0.10 earnings per share for the quarter, missing the analyst consensus estimate by $-0.03. Analysts had a consensus of $-0.07. The company posted revenue of $6.40 million in the period, compared to analysts expectations of $6.63 million. The company’s revenue was up 42.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $-0.11 EPS.
Mazor Robotics Ltd – ADR closed down -0.05 points or -0.45% at $11.14 with 1,19,770 shares getting traded on Friday. Post opening the session at $11.15, the shares hit an intraday low of $11.0305 and an intraday high of $11.36 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.
Mazor Robotics Ltd is an Israel-based medical device company that develops and markets surgical guidance systems and complementary products. It develops computerized and imaging-based systems in the field of spine surgery. Its products include: Renaissance Surgical Guidance System which enables surgeons to advance from freehand surgical procedures to guided procedures as well as Food and Drug Administration (FDA)-cleared and European Conformity (CE)-marked Renaissance System used in spine surgeries whether open or minimally invasive for a number of clinical indications. Its Renaissance System and its predecessor are used in a number of spine surgeries including fusion correction of spinal deformities biopsy collection tumor excision and cement augmentations. Furthermore the Company developed the Renaissance Brain Module an application of its Renaissance System that provides control over the insertion of surgical instruments during brain surgery.